Feb. 25 at 9:13 PM
$RXST Q4 '25 Earnings Results & Recap
• Reported GAAP EPS of -
$0.22 down -46.67% YoY
• Reported revenue of
$32.61M down -18.92% YoY
• RxSight provided full year 2026 guidance, projecting revenue of
$120.0 to
$135M, gross margin of 70% to 72%, and operating expenses between
$150M and
$160M, reflecting lower LDD placements.